Literature DB >> 19066729

Fatigue in low-grade glioma.

Karin Struik1, Martin Klein, Jan J Heimans, Marieke F Gielissen, Gijs Bleijenberg, Martin J Taphoorn, Jaap C Reijneveld, Tjeerd J Postma.   

Abstract

The aim of this study was to determine the prevalence and severity of fatigue in long-term survivors with a low-grade glioma (LGG), and to analyze the relationship between fatigue and demographic variables, disease duration, tumor characteristics, former tumor treatment modalities, antiepileptic drug (AED) use, self-reported concentration, motivation, and activity. Fifty-four patients with stable disease (age range, 25-73 years) who were diagnosed and treated more than 8 years ago were included in this study. Fatigue was analyzed with the Checklist Individual Strength (CIS). Thirty-nine percent of the LGG patients were severely fatigued, with older patients being most affected. Severe fatigue was associated with AED use, and with reduced self-reported concentration, motivation, and activity. No relation was found between fatigue and gender, histology, tumor laterality, disease duration, type of neurosurgical intervention and radiation treatment. Fatigue is a severe problem in a large proportion of long-term surviving LGG patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066729     DOI: 10.1007/s11060-008-9738-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

1.  High level of fatigue in lymphoma patients treated with high dose therapy.

Authors:  H Knobel; J H Loge; T Nordøy; A L Kolstad; T Espevik; S Kvaløy; S Kaasa
Journal:  J Pain Symptom Manage       Date:  2000-06       Impact factor: 3.612

2.  Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy.

Authors:  M J Taphoorn; A K Schiphorst; F J Snoek; J Lindeboom; J G Wolbers; A B Karim; P C Huijgens; J J Heimans
Journal:  Ann Neurol       Date:  1994-07       Impact factor: 10.422

3.  Occurrence of fatigue and associated factors in disease-free breast cancer patients without depression.

Authors:  Yuriko Sugawara; Tatsuo Akechi; Toru Okuyama; Yutaka Matsuoka; Tomohito Nakano; Masatoshi Inagaki; Shigeru Imoto; Maiko Fujimori; Takashi Hosaka; Yosuke Uchitomi
Journal:  Support Care Cancer       Date:  2005-01-25       Impact factor: 3.603

4.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

5.  Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale.

Authors:  T Okuyama; T Akechi; A Kugaya; H Okamura; S Imoto; T Nakano; I Mikami; T Hosaka; Y Uchitomi
Journal:  Support Care Cancer       Date:  2000-05       Impact factor: 3.603

6.  Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.

Authors:  Paul D Brown; Karla V Ballman; Teresa A Rummans; Matthew J Maurer; Jeff A Sloan; Bradley F Boeve; Lalit Gupta; David F Tang-Wai; Robert M Arusell; Matthew M Clark; Jan C Buckner
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

7.  Fatigue and fatigue-relieving strategies used by Hong Kong Chinese patients after hemopoietic stem cell transplantation.

Authors:  Winnie K W So; Josepha W M Tai
Journal:  Nurs Res       Date:  2005 Jan-Feb       Impact factor: 2.381

8.  Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

Authors:  G M Kiebert; D Curran; N K Aaronson; M Bolla; J Menten; E H Rutten; E Nordman; M E Silvestre; M Pierart; A B Karim
Journal:  Eur J Cancer       Date:  1998-11       Impact factor: 9.162

9.  Psychosocial problems among survivors of Hodgkin's disease.

Authors:  P Fobair; R T Hoppe; J Bloom; R Cox; A Varghese; D Spiegel
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

10.  Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life.

Authors:  Martin Klein; Nadine H J Engelberts; Henk M van der Ploeg; Dorotheé G A Kasteleijn-Nolst Trenité; Neil K Aaronson; Martin J B Taphoorn; Hans Baaijen; W Peter Vandertop; Martin Muller; Tjeerd J Postma; Jan J Heimans
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

View more
  28 in total

Review 1.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

2.  Lexical access speed is significantly correlated with the return to professional activities after awake surgery for low-grade gliomas.

Authors:  Sylvie Moritz-Gasser; Guillaume Herbet; Igor Lima Maldonado; Hugues Duffau
Journal:  J Neurooncol       Date:  2012-01-24       Impact factor: 4.130

3.  Occurrence and predictors of the fatigue in high-grade glioma patients.

Authors:  Irene Aprile; Silvia Chiesa; Luca Padua; Chiara Di Blasi; Maria Felice Arezzo; Vincenzo Valentini; Enrico Di Stasio; Mario Balducci
Journal:  Neurol Sci       Date:  2015-02-20       Impact factor: 3.307

4.  The association between cognitive functioning and health-related quality of life in low-grade glioma patients.

Authors:  Florien W Boele; Maaike Zant; Emma C E Heine; Neil K Aaronson; Martin J B Taphoorn; Jaap C Reijneveld; Tjeerd J Postma; Jan J Heimans; Martin Klein
Journal:  Neurooncol Pract       Date:  2014-05-06

Review 5.  Practical strategies for management of fatigue and sleep disorders in people with brain tumors.

Authors:  Terri S Armstrong; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

6.  Factors associated with supportive care needs in glioma patients in the neuro-oncological outpatient setting.

Authors:  Mirjam Renovanz; Marlene Hechtner; Mareile Janko; Karoline Kohlmann; Jan Coburger; Minou Nadji-Ohl; Jochem König; Florian Ringel; Susanne Singer; Anne-Katrin Hickmann
Journal:  J Neurooncol       Date:  2017-05-19       Impact factor: 4.130

Review 7.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

8.  The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.

Authors:  Terri S Armstrong; Elizabeth Vera-Bolanos; Alvina A Acquaye; Mark R Gilbert; Harshad Ladha; Tito Mendoza
Journal:  Neuro Oncol       Date:  2015-08-19       Impact factor: 12.300

9.  Mood disturbance in glioma patients.

Authors:  A A Acquaye; E Vera-Bolanos; T S Armstrong; M R Gilbert; L Lin
Journal:  J Neurooncol       Date:  2013-05-16       Impact factor: 4.130

Review 10.  Symptom management and quality of life in glioma patients.

Authors:  Florien W Boele; Martin Klein; Jaap C Reijneveld; Irma M Verdonck-de Leeuw; Jan J Heimans
Journal:  CNS Oncol       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.